about
Anti-vascular endothelial growth factor for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaIntravitreal steroids for macular edema in diabetesClinical development of new treatments for diabetic macular oedemaNew approaches for the treatment of diabetic macular oedema: recommendations by an expert panelInsulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studiesUpcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system.Combined therapy for diabetic macular edemaLaser-based strategies to treat diabetic macular edema: history and new promising therapies.Novel approaches to retinal drug delivery.The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes.Meta-analysis and review on the effect of bevacizumab in diabetic macular edema.Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability.Association of insulin treatment versus oral hypoglycaemic agents with diabetic retinopathy and its severity in type 2 diabetes patients in Cameroon, sub-Saharan Africa.Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis.
P2860
Q24193083-ABB7853C-7AA8-4516-87CD-19CC1CE228BCQ24202071-9F56FF14-3004-4A5C-AFA6-6D1109B6D5C1Q24240165-D93D307E-5C19-4CD4-BE9C-25549B4C271DQ24242242-A0D2AA90-C712-4FAA-9C1B-AEA346CDC16EQ24242456-E25B0BF9-D339-43EC-94BF-0CDFD04E8BA6Q26825365-A25B79F1-2A7C-4528-AD30-8159C382FBEEQ26853239-A6F697A7-2548-4A5B-9942-1882BF3E6839Q27010850-5EE07A05-6597-4FD9-A039-FE0AE31047F6Q33790255-3085A378-602D-4D11-9726-893C8E73E8B9Q35067115-BB3CC9AB-B81A-46BC-AFD5-137F60E98B59Q35353446-894DD3B0-654B-4662-B3CA-474FB34B9513Q36903801-2B4C56AB-E9FC-4049-B402-2818753FFA6AQ37218851-F133FB97-20D3-49FC-ABB8-02EE8B89AAD5Q37776162-30648CCC-1C34-4567-A596-E8580EDC5A18Q39069181-F2662326-21CB-4372-8419-65012ED4237DQ40465294-6B835DCE-E315-42F1-9256-4913F9518D6CQ42374458-8C410EC8-89EB-4D6E-AF54-4388DB9D9CA3
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Risk factors for diffuse and focal macular edema.
@ast
Risk factors for diffuse and focal macular edema.
@en
type
label
Risk factors for diffuse and focal macular edema.
@ast
Risk factors for diffuse and focal macular edema.
@en
prefLabel
Risk factors for diffuse and focal macular edema.
@ast
Risk factors for diffuse and focal macular edema.
@en
P2093
P1476
Risk factors for diffuse and focal macular edema.
@en
P2093
Isabel Méndez
Juan Fernández
Mercè Salvat
Pedro Romero Aroca
P304
P356
10.1016/S1056-8727(03)00038-2
P577
2004-07-01T00:00:00Z